Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
65.06 USD | +3.28% | +2.98% | +14.77% |
12:35pm | Stifel Upgrades LeMaitre Vascular to Buy From Hold, Adjusts Price Target to $75 From $59 | MT |
Mar. 12 | Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 1.41B | |
+8.25% | 218B | |
+7.02% | 182B | |
+11.63% | 132B | |
+27.05% | 108B | |
+13.17% | 52.98B | |
-0.62% | 47.59B | |
-0.65% | 39.96B | |
+11.72% | 39.22B | |
+25.87% | 26.94B |
- Stock Market
- Equities
- LMAT Stock
- News LeMaitre Vascular, Inc.
- Barrington Research Trims LeMaitre Vascular's Price Target to $54 From $62, Maintains Outperform Rating